Renal Solutions Announces FDA 510(k) Clearance Of The Allient(R) Sorbent Hemodialysis System For Chronic And Acute Hemodialysis  
6/8/2006 12:46:20 PM

WARRENDALE, Pa., June 8 /PRNewswire/ -- Renal Solutions, Inc., the exclusive provider of advanced sorbent hemodialysis products and services for treatment of patients with renal failure, announced today that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance of the Allient® Sorbent Hemodialysis System, including the SORB(TM) series and HISORB(TM) series cartridges, for chronic and acute hemodialysis applications. The FDA clearance of the Allient System addresses recent system enhancements which enable improved reliability and performance.